The potential of designing irreversible alkyne-based inhibitors of cysteine cathepsins by isoelectronic replacement in reversibly acting potent peptide nitriles was explored. The synthesis of the dipeptide alkynes was developed with special emphasis on stereochemically homogeneous products obtained in the Gilbert-Seyferth homologation for C≡C bond formation. Twenty-three dipeptide alkynes and 12 analogous nitriles were synthesized and investigated for their inhibition of cathepsins B, L, S, and K. Numerous combinations of residues at positions P1 and P2 as well as terminal acyl groups allowed for the derivation of extensive structure-activity relationships, which were rationalized by computational covalent docking for selected examples. The determined inactivation constants of the alkynes at the target enzymes span a range of >3 orders of magnitude (3-10 133 M-1 s-1). Notably, the selectivity profiles of alkynes do not necessarily reflect those of the nitriles. Inhibitory activity at the cellular level was demonstrated for selected compounds.
|Number of pages
|Journal of medicinal chemistry
|Published - 23 Mar 2023
- Azadipeptide nitrile, B expression, Bestmann-ohira reagent, Covalent inhibitors, Drug discovery, Ethynylglycine synthon, Occluding loop, Prognostic markers, Substrate-specificity, Terminal alkynes, Cysteine, Nitriles/chemistry, Structure-Activity Relationship, Dipeptides/chemistry, Cathepsin B, Cathepsins/metabolism, Cysteine Proteinase Inhibitors/chemistry